CONFERENCES

      International Conference on the Plant Family of Solanaceae

      International Conference on the Plant Family of Solanaceae is an event conference focusing on all aspects of the species of Solanaceae, with topics ranging from molecular breeding to epigenetics. The event is aimed at scientists and researchers that are involved with the plant family of Solanaceae, and provides a forum for sharing knowledge and collaborating to identify future trends in Solanaceae research.

      17th SOL Conference 2022

      Date

      Nov 01, 2022 - Nov 05, 2022

      Location

      Thessaloniki, Greece

      The XVII International Conference on the Plant Family of Solanaceae (SOL 2022) covers topics such as exploration of biodiversity and evolution, metabolomics, molecular breeding, genetics, genomics for quality and nutritional traits, abiotic and biotic stresses, epigenetics and more. This conference includes a talk by Nikolai Ivanov, PMI global head of biomarker & biosensor research, on the advances in Nicotiana omics resources.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.